Shareholder alert: pomerantz law firm investigates claims on behalf of investors of y-mabs therapeutics, inc. - ymab

New york , nov. 4, 2022 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of y-mabs therapeutics, inc. ("y-mabs" or the "company") (nasdaq: ymab). such investors are advised to contact robert s.

YMAB Ratings Summary

YMAB Quant Ranking